These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9027191)

  • 1. [Sleeping sickness as an import pathology following a stay in Zaire].
    Buyse D; Van den Ende J; Vervoort T; Van den Enden E
    Acta Clin Belg; 1996; 51(6):409-11. PubMed ID: 9027191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African sleeping sickness in the United States. Successful treatment with eflornithine.
    Petru AM; Azimi PH; Cummins SK; Sjoerdsma A
    Am J Dis Child; 1988 Feb; 142(2):224-8. PubMed ID: 3124603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital human African trypanosomiasis: an observation at the University Hospital of Brazzaville (Congo)].
    Oba A; Gahtse A; Ekouya Bowassa G; Nika E; Obengui
    Arch Pediatr; 2011 Oct; 18(10):1114-5. PubMed ID: 21873039
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible cases of sexual and congenital transmission of sleeping sickness.
    Rocha G; Martins A; Gama G; Brandão F; Atouguia J
    Lancet; 2004 Jan; 363(9404):247. PubMed ID: 14738812
    [No Abstract]   [Full Text] [Related]  

  • 7. Eflornithine for African sleeping sickness.
    Sjoerdsma A; Schechter PJ
    Lancet; 1999 Jul; 354(9174):254. PubMed ID: 10421331
    [No Abstract]   [Full Text] [Related]  

  • 8. African sleeping sickness.
    Hedley L; Fink D; Sparkes D; Chiodini PL
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
    [No Abstract]   [Full Text] [Related]  

  • 9. Eflornithine. A new drug in the treatment of sleeping sickness.
    Van Bogaert I; Haemers A
    Pharm Weekbl Sci; 1989 Jun; 11(3):69-75. PubMed ID: 2505225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rise and fall of sleeping sickness.
    Barrett MP
    Lancet; 2006 Apr; 367(9520):1377-8. PubMed ID: 16650633
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire.
    Pépin J; Milord F; Meurice F; Ethier L; Loko L; Mpia B
    Trans R Soc Trop Med Hyg; 1992; 86(3):254-6. PubMed ID: 1412646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
    Kuemmerle A; Schmid C; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Ngolo D; Kisala M; Valverde Mordt O
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008028. PubMed ID: 31986140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.
    Khonde N; Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human African trypanosomiasis transmission, Kinshasa, Democratic Republic of Congo.
    Simo G; Mansinsa Diabakana P; Kande Betu Ku Mesu V; Manzambi EZ; Ollivier G; Asonganyi T; Cuny G; Grébaut P
    Emerg Infect Dis; 2006 Dec; 12(12):1968-70. PubMed ID: 17326955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Ghorashian S; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):783-91. PubMed ID: 17128358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
    Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
    Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human African Trypanosomiasis in Emigrant Returning to China from Gabon, 2017.
    Wang X; Ruan Q; Xu B; Gu J; Qian Y; Chen M; Liu Q; Lu Q; Zhang W
    Emerg Infect Dis; 2018 Feb; 24(2):400-404. PubMed ID: 29350158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.
    Kazumba LM; Kaka JT; Ngoyi DM; Tshala-Katumbay D
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006504. PubMed ID: 29897919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Winterbottom's sign and hypertrophic cardiomyopathy.
    Stephan C; Just-Nuebling G; Fichtlscherer S; Kriener S; Brodt HR
    Scand J Infect Dis; 2002; 34(7):544-5. PubMed ID: 12195887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.